Financial Performance - The company's operating revenue for Q1 2025 reached ¥326,732,184.41, representing a 38.60% increase compared to ¥235,734,173.81 in the same period last year[4] - Net profit attributable to shareholders was ¥53,251,419.17, up 21.66% from ¥43,770,968.40 year-on-year[4] - Total operating revenue for Q1 2025 reached ¥326.73 million, a 38.54% increase from ¥235.73 million in Q1 2024[16] - Net profit for Q1 2025 was ¥53.25 million, representing a 21.51% increase compared to ¥43.77 million in Q1 2024[17] - Operating profit for Q1 2025 was ¥55.47 million, an increase of 14.04% from ¥48.34 million in Q1 2024[16] - The company reported a total profit of ¥60.53 million for Q1 2025, up 23.93% from ¥48.88 million in Q1 2024[17] Assets and Liabilities - The total assets increased by 34.51% to ¥4,027,399,359.79 from ¥2,994,235,626.06 at the end of the previous year[5] - As of March 31, 2025, the company's total assets reached CNY 4,027,399,359.79, an increase from CNY 2,994,235,626.06 as of December 31, 2024, reflecting a growth of approximately 34.5%[12] - The total current liabilities decreased to CNY 879,000,847.60 from CNY 976,082,140.46, a reduction of about 9.9%[14] - The total liabilities decreased to CNY 1,148,268,221.69 from CNY 1,245,003,307.87, a decrease of about 7.8%[14] Equity and Shareholder Information - The total equity attributable to shareholders increased by 64.59% to ¥2,879,131,138.10 from ¥1,749,232,318.19[5] - The company's equity attributable to shareholders increased to CNY 2,879,131,138.10 from CNY 1,749,232,318.19, marking a growth of approximately 64.5%[14] - The number of ordinary shareholders at the end of the reporting period was 19,194[9] - The top shareholder, Hubei Xingfa Chemical Group Co., Ltd., holds 39.93% of the shares, totaling 143,750,000 shares[9] Cash Flow and Expenses - The net cash flow from operating activities decreased by 42.26% to ¥20,955,865.00 from ¥36,294,141.20 in the previous year[4] - Cash flow from operating activities for Q1 2025 was ¥20.96 million, down 42.06% from ¥36.29 million in Q1 2024[19] - The company's cash and cash equivalents increased significantly to CNY 332,265,320.81 from CNY 126,584,381.08, representing a growth of about 162.3%[12] - Cash and cash equivalents at the end of Q1 2025 totaled ¥277.97 million, significantly up from ¥59.56 million at the end of Q1 2024[20] - Research and development expenses totaled ¥19,400,752.35, a 42.14% increase from ¥13,648,679.23, accounting for 5.94% of operating revenue[5] - Research and development expenses for Q1 2025 were ¥19.40 million, an increase of 42.36% from ¥13.65 million in Q1 2024[16] Other Financial Metrics - The weighted average return on equity decreased to 2.14% from 2.77%, a decline of 0.63 percentage points[4] - The company's retained earnings increased to CNY 420,609,834.45 from CNY 367,358,415.28, representing a growth of approximately 14.5%[14] - The company has not reported any significant changes in shareholder structure or participation in margin trading activities during the reporting period[10] - Basic earnings per share for Q1 2025 were ¥0.16, slightly down from ¥0.17 in Q1 2024[17] - The company generated net cash from financing activities of ¥1,033.62 million in Q1 2025, compared to ¥42.27 million in Q1 2024[20]
兴福电子(688545) - 2025 Q1 - 季度财报